COVID‐19 and liver cancer clinical trials: Not everything is lost.

COVID-19 and liver cancer clinical trials: Not everything is lost Keywords: BTC; clinical trials; COVID-19; HCC; liver cancer; SARS-CoV-2 EN BTC clinical trials COVID-19 HCC liver cancer SARS-CoV-2 1541 1544 4 06/25/20 20200701 NES 200701 Since the first cases in Wuhan, China, during the month of December 2019, coronavirus disease (COVID-19) evolved into a worldwide emergency, becoming one of the deadliest pandemics of modern history. Furthermore, these patients do not always have a valid therapeutic standard-of-care alternative, so for us it was of utmost importance to ensure the continuum of care for these patients even during the pandemic. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. [Extracted from the article]